Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
Xin Wang, Linli Tian, Yushan Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 240
Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 131
The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms
Qibo Huang, Jie Mo, Zhibin Liao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 66
TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury
Hao Zhou, Zhe Dai, Jialei Li, et al.
Metabolism (2023) Vol. 140, pp. 155383-155383
Closed Access | Times Cited: 50
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential
Tianyu Zhu, Lian‐Lian Hong, Zhi‐Qiang Ling
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 41
IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD
Chenying Han, Chenchen Hu, Tianyue Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 13
The impact of hypoxia on immune state in cancer
Keywan Mortezaee, Jamal Majidpoor
Life Sciences (2021) Vol. 286, pp. 120057-120057
Closed Access | Times Cited: 66
RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner
Xianlei Cai, Yunhao Chen, Da Man, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 58
METTL3 promotes colorectal carcinoma progression by regulating the m6A–CRB3–Hippo axis
Jiashu Pan, Feng Liu, Xiaoli Xiao, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 57
IGF2BP3 is an essential N6-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
Xin Xu, Jiangtao Cui, Hong Wang, et al.
Materials Today Bio (2022) Vol. 17, pp. 100503-100503
Open Access | Times Cited: 55
The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer
Chao‐Yue Sun, Cao Di, Bin-Bin Du, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2744-2758
Open Access | Times Cited: 48
Circ‐CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15
Feng Yang, Yang Liu, Jun Xiao, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 43
MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma
Mingyu Du, Yi Peng, Li Yang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 42
Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11
Xing Zeng, Ke Chen, Le Li, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 135-147
Closed Access | Times Cited: 41
N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
Zhiying Zhao, Qiang Ju, Jing Ji, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 36
AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification
Hong Wang, Liu Ji, Xiaojun Zhu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 26
IGF2BP3-stabilized CAMK1 regulates the mitochondrial dynamics of renal tubule to alleviate diabetic nephropathy
Yuan Du, Hao Li, Wenni Dai, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167022-167022
Closed Access | Times Cited: 6
YTHDF2 mediates the protective effects of MG53 on myocardial infarction injury via recognizing the m6A modification of MG53
Zhaojie Li, Kai Li, Jianqiang Zhao
Journal of Cardiothoracic Surgery (2025) Vol. 20, Iss. 1
Open Access
METTL3‐mediated NFAT5 Upregulation Promotes Cervical Cancer Progression Through Enhancing the Mitochondrial Function by Transcriptional Regulation of PRDX1
Yanli He, Junli Ge, Shuhua Zhao, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy
Sahib Zada, Jin Seok Hwang, Mahmoud Ahmed, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188565-188565
Open Access | Times Cited: 49
Fluid shear stress activates YAP to promote epithelial–mesenchymal transition in hepatocellular carcinoma
Hongchi Yu, Jia He, Guanyue Su, et al.
Molecular Oncology (2021) Vol. 15, Iss. 11, pp. 3164-3183
Open Access | Times Cited: 39
Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer
Libin Jiang, Yingxia Li, Yixin He, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 39
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Richard J. Sové, Babita K. Verma, Hanwen Wang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005414-e005414
Open Access | Times Cited: 33
Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer
Xin Huang, Haoyu Guo, Lutong Wang, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 27, pp. 947-955
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top